Evidence map›Paper›PMID 41533261›Full record

ReviewCurrent urology reports2026

Beyond Sterility: the Urinary Microbiome in Bladder Cancer Carcinogenesis and Treatment.

Stephanie Aron, Margaret Meagher, Sarah Azari, Benjamin Baker, Ryan Nasseri, Aditya Bagrodia, Tyler Stewart, Michael Liss, Amirali Salmasi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current urology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stephanie AronDepartment of Urology, University of California, San Diego, CA, USA.
Margaret MeagherDepartment of Urology, University of California, San Diego, CA, USA.
Sarah AzariDepartment of Urology, University of California, San Diego, CA, USA.
Benjamin BakerDepartment of Urology, University of California, San Diego, CA, USA.
Ryan NasseriDepartment of Urology, University of California, San Diego, CA, USA.
Aditya BagrodiaDepartment of Urology, University of California, San Diego, CA, USA.
Tyler StewartDepartment of Medicine, University of California, San Diego, CA, USA.
Michael LissDepartment of Urology, University of California, San Diego, CA, USA.
Amirali SalmasiDepartment of Urology, University of California, San Diego, CA, USA. asalmasi@health.ucsd.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewEmerging evidence has challenged the paradigm of bladder sterility, opening new opportunities for understanding bladder cancer biology. RECENT

findingsDisruption of commensal intravesical bacterial communities appears to increase risk of carcinogenesis, while the presence of specific bacterial strains has been linked to differential treatment responses. However, the interplay between urinary microbiome and bladder cancer remains incompletely defined. This review summarizes the current literature regarding the role of urinary microbiome in the pathogenesis and treatment outcomes, highlights limitations of existing studies, and outlines future directions for incorporating microbiome profiling into personalized management strategies.

Indexed as

CarcinogenesisMicrobiotaUrinary BladderUrinary Bladder NeoplasmsHumansBladder cancerCarcinogenesisMicrobiomeTreatment effects

Identifiers

PMID41533261

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.